Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China.

Cardio-oncology (London, England)·2026
Same author

Extracellular Vesicles in Wearable Delivery Systems for Cosmeceutical Applications.

Advanced healthcare materials·2026
Same author

A knowledge graph-driven paradigm for holistic symptom management: development and evaluation of a nurse-led KG-QA system in community palliative care.

BMC palliative care·2026
Same author

Integrated directed evolution and semirational design of Pyrococcus furiosus Argonaute for ultrasensitive tetracycline detection.

Trends in biotechnology·2026
Same author

Interface-Triggered Bulk Electrical Coupling in SnO<sub>2</sub> via Mesoscopic Chemical Reconfiguration for Scalable, High-Efficiency Perovskite Photovoltaics.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

2D Semiconductor Hexagonal Boron Nitride Towards Broad Optoelectronic Applications.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Jul 14, 2026

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

A protein chip approach for high-throughput antigen identification and characterization.

Shaohui Hu1, Yu Li, Guozhen Liu

  • 1Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.

Proteomics
|June 6, 2007
PubMed
Summary

Researchers developed a new method for producing high-quality monoclonal antibodies (mAbs) against human liver proteins. This technique identified a protein, eIF1A, that is present in normal liver tissue but absent in hepatocellular carcinoma.

More Related Videos

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Proteomics research requires numerous high-quality monoclonal antibodies (mAbs).
  • Existing methods for mAb production can be time-consuming and may not yield sufficient specificity for complex proteomic studies.

Purpose of the Study:

  • To establish a novel, high-throughput approach for generating high-quality mAbs against human liver proteins.
  • To identify specific liver proteins and their expression patterns, particularly in relation to cancer.

Main Methods:

  • Combined high-throughput hybridoma production with protein microarray screening.
  • Immunized mice with human liver cells and screened resulting hybridomas against a microarray of 1058 human liver proteins.
  • Validated antigen expression using tissue microarrays.

Main Results:

  • Successfully produced 54 hybridomas with binding activity to human liver cells.
  • Identified specific antigens for five mAbs through protein microarray analysis.
  • Demonstrated the utility of these mAbs in characterizing antigen expression profiles.
  • Discovered that eIF1A is exclusively expressed in normal liver tissues, not in hepatocellular carcinoma.

Conclusions:

  • The developed approach is effective for producing high-quality mAbs against human liver proteins.
  • The identified mAbs can serve as valuable tools for characterizing protein expression in liver tissues.
  • The discovery of eIF1A's differential expression highlights its potential as a biomarker for hepatocellular carcinoma.